Literature DB >> 163261

Sclerosteosis. A case report.

Y Sugiura, T Yasuhara.   

Abstract

Entities:  

Mesh：

Year:  1975        PMID： 163261

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN： 0021-9355            Impact factor:   5.284


× No keyword cloud information.
  12 in total

1.  Case report 546: Endosteal hyperostosis (Worth type).

Authors:  T Irie; M Takahashi; M Kaneko
Journal:  Skeletal Radiol       Date:  1989       Impact factor: 2.199

Review 2.  Craniotubular bone disorders.

Authors:  R J Gorlin
Journal:  Pediatr Radiol       Date:  1994

3.  Localization of the gene for sclerosteosis to the van Buchem disease-gene region on chromosome 17q12-q21.

Authors:  W Balemans; J Van Den Ende; A Freire Paes-Alves; F G Dikkers; P J Willems; F Vanhoenacker; N de Almeida-Melo; C F Alves; C A Stratakis; S C Hill; W Van Hul
Journal:  Am J Hum Genet       Date:  1999-06       Impact factor: 11.025

Review 4.  Sclerostin: therapeutic horizons based upon its actions.

Authors:  Aline G Costa; John P Bilezikian
Journal:  Curr Osteoporos Rep       Date:  2012-03       Impact factor: 5.096

5.  Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein.

Authors:  M E Brunkow; J C Gardner; J Van Ness; B W Paeper; B R Kovacevich; S Proll; J E Skonier; L Zhao; P J Sabo; Y Fu; R S Alisch; L Gillett; T Colbert; P Tacconi; D Galas; H Hamersma; P Beighton; J Mulligan
Journal:  Am J Hum Genet       Date:  2001-02-09       Impact factor: 11.025

6.  Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease.

Authors:  W Balemans; N Patel; M Ebeling; E Van Hul; W Wuyts; C Lacza; M Dioszegi; F G Dikkers; P Hildering; P J Willems; J B G M Verheij; K Lindpaintner; B Vickery; D Foernzler; W Van Hul
Journal:  J Med Genet       Date:  2002-02       Impact factor: 6.318

7.  Camurati-Engelmann disease: imaging, clinical features and differential diagnosis.

Authors:  Aldona Bartuseviciene; Arturas Samuilis; Jovitas Skucas
Journal:  Skeletal Radiol       Date:  2009-02-12       Impact factor: 2.199

8.  Sclerosteosis in a Spanish male: first report in a person of Mediterranean origin.

Authors:  M Bueno; G Oliván; A Jiménez; J M Garagorri; A Sarría; A L Bueno; M Bueno; F J Ramos
Journal:  J Med Genet       Date:  1994-12       Impact factor: 6.318

Review 9.  A review of the osteopetroses.

Authors:  P Beighton; F Horan; H Hamersma
Journal:  Postgrad Med J       Date:  1977-08       Impact factor: 2.401

10.  Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist.

Authors:  Rutger L van Bezooijen; Bernard A J Roelen; Annemieke Visser; Lianne van der Wee-Pals; Edwin de Wilt; Marcel Karperien; Herman Hamersma; Socrates E Papapoulos; Peter ten Dijke; Clemens W G M Löwik
Journal:  J Exp Med       Date:  2004-03-15       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.